• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

Implementation of High Dose Rate Brachytherapy in Limited Resource Settings

English STI/PUB/1670 978-92-0-107214-6
97 21 45.00 2015

Download PDF (1.74 MB)

Description

Brachytherapy is an essential component of the curative treatment of cervical cancer, a disease with high incidence in many developing countries. The IAEA supports the use of high dose rate (HDR) brachytherapy for centres with a large number of patients with this disease. HDR brachytherapy is also used in other common cancers such as breast, lung, oesophagus and prostate cancer. This publication provides guidance to radiation oncologists, medical physicists and planners on establishing and operating an HDR brachytherapy unit with modern standards, and presents the main issues to be addressed for its effective and safe operation.

More Information on reusing IAEA copyright material.

Keywords

IAEA Human Health, Medical Physics, Radioisotope Brachytherapy, Cancer, Radiotherapy, Safety Measures, High Dose Rate, HDR, Developing Countries, Patients, Medical Personnel, Prostate, Oesophagus, Cervical, Breast Cancer, Lungs, Assessment, Infrastructure

How to order

Ordering Locally

Please use the following links for an up-to-date list of IAEA distributors:

Distributors of IAEA Publications


Orders and requests for information may also be addressed to:

Marketing and Sales Unit
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria

Tel.: +43 1 2600 22529, +43 1 2600 22530
Fax: +43 1 2600 29302
Email: sales.publications@iaea.org


Download order form

Resources

  1. Employment
  2. Women
  3. Press

Stay in touch

Newsletter